General drug-use survey for Corectim

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT2031210295

Enrollment

3000

Registered

2021-09-05

Start date

2021-10-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatitis atopic

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients using Corectim for the first time for dermatitis atopic (2) Patients or their surrogates must provide informed consent before the start

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Incidence of onset of skin infection Incidence of onset of malignant tumor	—

Contacts

Public ContactPatient Safety Dept.

Shionogi & Co., Ltd.

DL_pms-pharma@shionogi.co.jp+81-80-1054-2168

Outcome results